| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT05705414 Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease… |
date change Primary completion pushed: 2026-06 -> 2026-10-30 |
| 2026-08-06 | NCT05294991 Wellness App for Sleep Disturbance in Hematological Cancer Patients |
Enrollment closed, study ongoing |
| 2026-08-06 | NCT05294991 Wellness App for Sleep Disturbance in Hematological Cancer Patients |
date change Primary completion pushed: 2026-10-31 -> 2026-12-20 |
| 2026-08-06 | NCT05294991 Wellness App for Sleep Disturbance in Hematological Cancer Patients |
date change Completion pushed: 2026-10-31 -> 2026-12-20 |
| 2026-07-31 | NCT06133283 Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and… |
Trial completed |
| 2026-07-31 | NCT06133283 Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and… |
date change Primary completion moved earlier: 2026-12-31 -> 2025-11-11 |
| 2026-07-31 | NCT06133283 Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and… |
date change Completion moved earlier: 2026-12-31 -> 2025-11-11 |
| 2026-07-30 | NCT03878459 Dapagliflozin Plus Pioglitazone in T1DM |
Enrollment closed, study ongoing |
| 2026-07-30 | NCT03878459 Dapagliflozin Plus Pioglitazone in T1DM |
date change Primary completion moved earlier: 2027-06 -> 2026-03-15 |
| 2026-07-30 | NCT03878459 Dapagliflozin Plus Pioglitazone in T1DM |
date change Completion pushed: 2027-12 -> 2027-12-31 |
| 2026-07-24 | NCT07348796 Real World Evaluation of the Effectiveness and Implementation of a Digital Health… |
date change Primary completion pushed: 2027-08-31 -> 2028-05-31 |
| 2026-07-24 | NCT07348796 Real World Evaluation of the Effectiveness and Implementation of a Digital Health… |
date change Completion pushed: 2027-08-31 -> 2028-06-30 |
| 2026-07-19 | NCT07056699 SGLT2i, Pioglitazone, and Ketone Production in T1D |
Recruitment opened |
| 2026-07-19 | NCT07053319 SGLT2i, Pioglitazone, and Ketone Production in T2D |
Trial arms changed: 4 -> 3 |
| 2026-07-19 | NCT07565753 TEAPOT Study Multisite |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-24 | NCT07725731 The Anesthetic and Analgesic Effect of Adjunct Liposomal Bupivacaine in Periodontal… | Phase 1/2 | Completed |
| 2026-07-20 | NCT07713199 Free Soft Tissue Grafts FSTG) Using Autograft Palatal Donor Tissue vs. Xenograft Collagen… | Not Yet Recruiting | |
| 2026-07-20 | NCT07715799 Noninvasive Brain Stimulation Combined With Written Exposure Therapy for PTSD in Military… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT03765567 | Placement of Antibiotic Powder in Wounds During the Emergency Room | Open Fracture | Recruiting |
| NCT05838287 | Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants | Type 2 Diabetes Mellitus in Obese | Recruiting |
| NCT05590637 | Comparing Antipsychotic Medications in LBD Over Time | Parkinson's Disease Psychosis | Recruiting |
| NCT05305287 | Quantifying Hepatic Mitochondrial Fluxes in Humans | Non-Alcoholic Fatty Liver Disease | Recruiting |
| NCT03878459 | Dapagliflozin Plus Pioglitazone in T1DM | Type 1 Diabetes Mellitus | Active, Not Recruiting |
| Phase 3 | |||
| NCT06246799 | Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent… | Type 2 Diabetes (Adult Onset) | Recruiting |
| NCT07056699 | SGLT2i, Pioglitazone, and Ketone Production in T1D | Type1diabetes | Recruiting |
| Phase 2/3 | |||
| NCT05696691 | Ketamine & Crisis Response Plan for Suicidal Ideation in the ED | Suicide | Recruiting |
| Phase 2 | |||
| NCT04863950 | Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent… | Glioblastoma | Recruiting |
| NCT05889741 | Combining Stellate Ganglion Block With Prolonged Exposure for PTSD | Stress Disorders, Post-Traumatic | Recruiting |
| NCT06526104 | Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular… | Hepatocellular Carcinoma | Recruiting |
| NCT04559230 | Sacituzumab Govitecan in Recurrent Glioblastoma | Recurrent Glioblastoma | Recruiting |
| NCT06811324 | Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults | Obesity Prevention | Recruiting |
| NCT04081220 | Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential… | Thrombocythemia, Essential | Active, Not Recruiting |
| NCT07470606 | Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain | Brain Tumor | Not Yet Recruiting |
| NCT04629495 | Rapamycin - Effects on Alzheimer's and Cognitive Health | Mild Cognitive Impairment | Active, Not Recruiting |
| NCT05720325 | Dupilumab Effects Against Aeroallergen Challenge | Asthma, Allergic | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06609343 | Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis | End Stage Renal Disease | Not Yet Recruiting |
| Phase 1 | |||
| NCT07137871 | Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast… | Breast Cancer Metastatic | Recruiting |
| NCT06446531 | Prevention of Progression of Prediabetes, Obesity and CV Risk | Pre-Diabetes | Recruiting |
| NCT07212868 | The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery | Non-Diabetic | Recruiting |
| NCT06977711 | Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP)… | Diffuse Large B-cell Lymphoma | Recruiting |
| NCT05960656 | SGLTi, Hepatic Glucose Production and Ketogenesis | Type 2 Diabetes | Recruiting |
| NCT07053306 | SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia | Type 2 Diabetes | Recruiting |
| NCT07053319 | SGLT2i, Pioglitazone, and Ketone Production in T2D | Type 2 Diabetes | Recruiting |